The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
02/17/2023 | Rob Coker | 3 min read
Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza
02/15/2023 | Rob Coker | 3 min read
As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments
02/10/2023 | Robin Röhm | 5 min read
AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset
02/08/2023 | Rob Coker | 9 min read
Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments
02/07/2023 | Oliver Eden | 5 min read
How digital health technology can help clinical trials be more inclusive and accessible.
02/03/2023 | Rob Coker | 2 min read
Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators
01/30/2023 | Angus Stewart | 8 min read
An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease
01/25/2023 | Angus Stewart
How a complex but common carbohydrate could help add a new dimension to 3D-printed pills
01/23/2023 | Rob Coker | 9 min read
UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.
01/19/2023 | Graeme Smith, Niall Martin | 6 min read
Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse